Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease

Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease

Background. The study of drug availability for patients with chronic obstructive pulmonary disease (COPD) represents one of the priority tasks in the organization of effective counteraction to COPD in the Russian Federation.Objective: to assess drug prices, affordability, and availability for COPD p...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. A. Orlova, V. I. Petrov, I. P. Dorfman, O. V. Shatalova, M. A. Orlov
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2024-05-01
Series:	Фармакоэкономика
Subjects:	chronic obstructive pulmonary disease copd drug prices drug affordability drug availability atc/ddd analysis
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/964
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical and economic analysis of drug costs in a general hospital in 2014-2018
by: A. T. Burbello, et al.
Published: (2020-02-01)

Assessment of Prescribing Pattern of antibiotics by Dentists in Ardabil city Based on the International ATC/DDD System
by: Mehrnoosh Kaviani, et al.
Published: (2024-07-01)

Analysis of methotrexate use practice in patients with rheumatoid and psoriatic arthritis
by: S. A. Doktorova, et al.
Published: (2025-05-01)

POLYPHARMACY IN MANAGMENT OF IN-PATIENTS WITH NOVEL CORONAVIRUS DISEASE (COVID-19)
by: V. I. Petrov, et al.
Published: (2022-07-01)

Impacts of National Reimbursement Drug Price Negotiation on drug accessibility, utilization, and cost in China: a systematic review
by: Zheng Zhu, et al.
Published: (2025-02-01)

Analysis of the availability and affordability of pharmaceuticals for children in need of palliative care
by: D. M. Medvedeva, et al.
Published: (2021-07-01)

Assessment of Antibiotic Use in ICU Patients with Pneumonia Using ATC/DDD as a Quantitative Analysis Method
by: Mareta Rindang Andarsari, et al.
Published: (2022-08-01)

Analysis of the Consumption of Medicinal Products Associated with a High Risk of Drug-Induced Liver Injury in Patients with COVID-19
by: V. I. Petrov, et al.
Published: (2024-10-01)

Appointment of Antimicrobial Medications in a Hospital Depending on the Results of Microbiological Monitoring of HAI
by: S. D. Mitrokhin, et al.
Published: (2020-12-01)

РОЛЬ АТС/DDD-МЕТОДОЛОГИИ В ОПТИМИЗАЦИИ ЛЕЧЕНИЯ БОЛЬНЫХ С ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ
by: А. Л. Хохлов, et al.
Published: (2013-02-01)

Contemporary State of Antibiotic Resistance in Opportunistic Pathogens and the Extent of Antibiotic Use in the Third-Level Federal Obstetric Hospital
by: D. M. Serdyukova, et al.
Published: (2020-05-01)

Impact of the National Drug Price Negotiation policy on the price, usage, and affordability of anticancer medicines in Shandong Province, China
by: Yaqun Sun, et al.
Published: (2025-01-01)

Analysis of the availability of bronchodilators listed in the medical insurance catalog for treatment of chronic obstructive pulmonary disease in community health service centers in Shanghai
by: DENG Hui, et al.
Published: (2025-05-01)

Analysis of Antibiotic Use in COVID-19 Patients at a Hospital in Sidoarjo
by: Weni Kristanti, et al.
Published: (2022-08-01)

Access to single-inhaler triple medicines for chronic obstructive pulmonary disease in China: a national survey on accessibility and utilisation
by: Wei Li, et al.
Published: (2025-12-01)

Genetic Association of Lipid-Lowering Drug Target Genes with Chronic Obstructive Pulmonary Disease: A Mendelian Randomization Study
by: Hao Luan, et al.
Published: (2025-12-01)

The diagnostic value of bronchodilator response in differentiating asthma, COPD, and ACO in fixed airflow obstruction: a retrospective study
by: Müge Erbay, et al.
Published: (2025-07-01)

Endothelial dysfunction in patients with chronic obstructive pulmonary disease: some aspects of medicamental treatment (a literature review)
by: O. I. Lemko, et al.
Published: (2021-02-01)

EFFECT OF BRONCHODILATORS ON HEART RATE VARIABILITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: H. H. Shugushev, et al.
Published: (2015-12-01)

Access to pediatric oncology medicine in Iran: a cross-sectional survey in Urmia
by: Kiana Baghban, et al.
Published: (2025-08-01)

Therapeutic effect of phycocyanin on chronic obstructive pulmonary disease in mice
by: Wenjun Li, et al.
Published: (2024-12-01)

Implications and size of trade in anti-infective drugs a.u.v. and About the drafting of medical and veterinary ordinances in Romania
by: Romeo T. Cristina
Published: (2023-06-01)

Levels of T-regulatory cells in patients with chronic obstructive pulmonary disease and basis therapy efficiency
by: N. A. Kirillova, et al.
Published: (2012-12-01)

ADMINISTRATIVE AND ORGANIZATIONAL ASPECTS OF FUNCTIONING OF THE SYSTEM OF AVAILABILITY NARCOTIC AND PSYCHOTROPIC MEDICINAL PREPARATIONS FOR PATIENTS WHO NEED THEM
by: I. A. Kaminskaya, et al.
Published: (2017-03-01)

Improving the Inhalation Technique in Patients with Obstructive Pulmonary Diseases
by: Zlatina Ivanova, et al.
Published: (2016-12-01)

Assessment of Long-Term Pulmonary Function and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD)
by: Sanjay D. Gabhale, et al.
Published: (2024-08-01)

The role of the microbiota components in modification of the immune response in some cases of chronic obstructive pulmonary disease
by: Natalia A. Kirillova, et al.
Published: (2017-07-01)

Prevalence of Chronic Obstructive Pulmonary Disease and Asthma in the Community of Pathumthani, Thailand
by: Narongkorn Saiphoklang, et al.
Published: (2025-04-01)

Bronchodilator reversibility test for broncho-obstructive syndrome detection and differential diagnosis of bronchial asthma and chronic obstructive pulmonary disease
by: V. P. Melnyk, et al.
Published: (2019-04-01)

Effectiveness of Interventions to Reduce Sedentary Behaviour in People with Chronic Obstructive Pulmonary Disease: A Systematic Review of Randomised Controlled Trials
by: Stefanie Harding, et al.
Published: (2025-03-01)

Sub-Optimal Chronic Obstructive Pulmonary Disease (COPD) Management in India: Findings from a Community-Based Study
by: Jarhyan P, et al.
Published: (2025-06-01)

Pulmonary Rehabilitation and Physical Activity in COPD
by: Natalia Tylczyńska, et al.
Published: (2025-06-01)

Identification and validation for biomarkers associated with mitochondrial metabolism in chronic obstructive pulmonary disease
by: Wenjun Wang, et al.
Published: (2025-08-01)

PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION
by: T. V. Gaygolnik, et al.
Published: (2016-09-01)

Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available
by: F. V. Gorkavenko, et al.
Published: (2019-07-01)

T-regulatory cells subpopulation in bronchial asthma and heterogeneous phenotypes of chronic obstructive pulmonary disease
by: N. A. Kirillova, et al.
Published: (2011-02-01)

Assessing the acceptability, affordability, and availability of teleoncology services among cancer patients: A cross-sectional study
by: Praveen Suthar, et al.
Published: (2025-07-01)

The Indian Battle of Selecting a Brand versus Generic Medicine Continues: A Cost Variation Study of Oral Fluoroquinolones
by: Pallavi Dhanvijay, et al.
Published: (2025-03-01)

Chronic obstructive pulmonary disease and chronic heart failure in elderly people: literature review
by: V. A. Gubkina, et al.
Published: (2016-06-01)

Clinical and sleep-related characteristics as predictors for risk of dysphagia in patients with chronic obstructive pulmonary disease
by: Gabriele dos Anjos Palagi da Silva, et al.
Published: (2025-08-01)